Cargando…
Transient Complete Recovery of Chronic Refractory Idiopathic Thrombocytopenic Purpura after Treatment with Monoclonal Antibody Targeting SARS-CoV-2 Spike Protein
Idiopathic thrombocytopenic purpura (ITP), also known as immune thrombocytopenic purpura, is an immune-mediated acquired disease characterized by transient or persistent decrease of the platelet count due to autoimmune-related destruction of platelets. Therapy for ITP relies on competing and inhibit...
Autores principales: | Gogia, Pooja, Xu, Yiqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172208/ https://www.ncbi.nlm.nih.gov/pubmed/35685064 http://dx.doi.org/10.1155/2022/8335541 |
Ejemplares similares
-
Idiopathic thrombocytopenic purpura
por: Kayal, L., et al.
Publicado: (2014) -
Octaploidy in idiopathic thrombocytopenic purpura
por: Makroo, R. N., et al.
Publicado: (2011) -
Therapeutic effects of rituximab combined with cyclophosphamide on refractory idiopathic thrombocytopenic purpura
por: Wang, Jiuhe, et al.
Publicado: (2019) -
Thrombotic Thrombocytopenic Purpura: Revisiting a Miss and an Inevitable Consequence
por: Gogia, Pooja, et al.
Publicado: (2020) -
Secondary Immune Thrombocytopenic Purpura Triggered by COVID-19
por: Watts, Abi, et al.
Publicado: (2021)